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Human infections involving yeast of the genus Candida oen occur in the presence of bacteria, and, as such, it is important
to understand how these bacteria in�uence innate host immunity towards Candida. Dectin-1 is a cell receptor of macrophages
for Candida albicans recognition. e aim of this study was to examine dectin-1 expression by monocytes aer stimulation with
bacterial lipopolysaccharide (LPS), followed by heat-killed C. albicans (HKC). Freshly isolated human peripheral blood monocytes
(PBMCs) and human monocytes cell line (THP-1) cells expressed low levels of dectin-1. Stimulation with LPS and GM-CSF/IL-4
was found to increase dectin-1 expression in both CD14+ human PBMC and THP-1 cells. Enhanced dectin-1 expression resulted in
increased phagocytosis of Candida. When THP-1 cells were challenged only with HKC, detectable levels of IL-23 were not evident.
However, challenge by LPS followed by varying concentrations of HKC resulted in increased IL-23 expression by THP-1 cells in
HKC dose-dependent manner. Increased expression of IL-17 by PBMC also occurred aer stimulation with Candida and LPS. In
conclusion, bacterial LPS induces an enhanced immune response to Candida by immune cells, and this occurs through increasing
dectin-1 expression.
1. Introduction
Yeast of the genus Candida are frequently carried as harmless
commensals at body sites such as the skin, gut, oral cavity,
and vaginal tract. However, these fungi are opportunis-
tic pathogens of humans and able to cause serious and
potentially life-threatening systemic infections in severely
immunocompromised individuals [1–3].Most infections are,
however, super�cial, a�ecting the moist mucosal surfaces
of the oral cavity and vagina in debilitated individuals. e
occurrence of super�cial oral candidosis may arise from a
multitude of factors including local immune suppression,
reduced salivary �ow, poor oral hygiene, smoking, denture
wearing, hormonal imbalances, and nutritional de�ciencies
[4–8]. Furthermore, receipt of broad-spectrum antibiotics
has also been implicated with subsequent mucosal and
systemic candidal infection [9].
e mechanism of immune recognition of Candida by
the host has been the focus of a number of recent stud-
ies. Cells of the innate immune system express an array
of pattern recognition receptors (PPRs) such as toll-like
receptors (TLRs), which are important in the recognition of
microorganisms. Host innate immune cells also express C-
type lectin receptors (e.g., dectin-1 and dectin-2) which are
PPRs that are key for Candida albicans recognition [10, 11].
Dectin-1 is a cell surface molecule exhibiting an inducible
expression pattern and an ability to bind to 𝛽𝛽-glucan, which
is a major carbohydrate component in the cell wall of C.
albicans [12, 13]. Recognition of C. albicans by dectin-1 not
only leads to the formation of receptor synapses for Candida
phagocytosis [14], but also triggers cell signalling for cytokine
production [15]. Dectin-1 de�ciency in humans has been
shown to be associated with the development of chronic
Candida infection [16].
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Engagement of dectin-1 by Candida initiates cell sig-
nalling through spleen tyrosine kinase (Sky) activation and
the CARMA1-related adaptor protein, CARD9, then further
downstream activation of NFkB activity for cytokine produc-
tion [17].e cell signal triggered by dectin-1 also induces IL-
10 and IL-2 production in dendritic cells (DCs) [18] as well
as cytokines of the IL-12 family [17]. Some of the cytokines
produced by DCs promote 1 and 17 cell diﬀerentiation
resulting in protective immune responses towards infecting
fungi [19]. A17 response has convincingly been shown to
be critical in the host immune response to C. albicans infec-
tion in animal models [3, 20]. e cytokine IL-23, together
with TGF𝛽𝛽 and IL-1𝛽𝛽, promotes17 diﬀerentiation and the
maintenance of higher IL-17 production [21, 22].
Apart from cytokine production by macrophages and
DCs, the other important feature in innate immunity is
phagocytosis. Phagocytosis is the ability of macrophages
and DCs to engulf the pathogen aer its recognition by
appropriate cell receptors [23–26]. Candida killing within
a phagosome fused with endosomes and lysosome subse-
quently occurs [27].
Mucosal colonisation of C. albicans occurs at a higher
incidence in patients receiving long-term or broad-spectrum
antibiotic treatment. is may result from the loss of local
competition for Candida for nutrients and receptor sites,
although an in�uence on the immune system cannot be dis-
counted. Importantly, limited studies have been undertaken
with regards to this latter factor.
In the present study, we have found that human innate
immune cells, CD14+ human peripheral blood monocytes
(PBMCs), and THP-1 human monocytes exhibit inducible
expression of dectin-1 for Candida phagocytosis and IL-23
production. Also, bacterial LPS enhances C. albicans induced
IL-17 (a key cytokine in yeast immunity) production in
human PBMCs. e results generated in this study demon-
strated that bacteria existing atmucosal sitesmight have a role
in assisting host innate immune cells in Candida recognition.
is is clearly an important consideration for the treatment
and management of patients with Candidawho are in receipt
of antibiotic therapy.
2. Material andMethods
2.1. Cell Culture and Stimulation. Collection and isolation of
human PBMC from healthy volunteers was done following
approval by Cardiﬀ University (DENTL 09/18). Human
PBMCs were isolated using density gradient centrifugation
as recommended by the manufacturer (GE Life Science,
UK). Cells were cultured (with or without stimulation)
at 37∘C in a 5% CO2 enriched atmosphere in RPMI1640
medium supplemented with 10% foetal bovine serum (FBS),
containing penicillin and streptomycin. Human THP-1 cells
were also cultured in RPMI1640 medium with passage every
3-4 days.
To investigate dectin-1 expression in human monocytes,
the cells were stimulated with increasing concentrations
of lipopolysaccharide (LPS) extracted from Escherichia coli
(Sigma Ltd., UK) followed by challenge with heat-killed
Candida (HKC) or culture negative controls. Cells were then
cultured for diﬀerent time periods before harvesting and
analysis for dectin-1 expression and cytokine production.
2.2. Preparation of Heat-Killed C. albicans. ree well-char-
acterised clinical isolates of C. albicans were used for the
challenge studies [28]. e isolates had previously been
identi�ed based on traditional biochemical analysis as well
as sequencing of rDNA gene sequences. e isolates were
cultured overnight at 37∘C in yeast nitrogen base medium
supplemented with glucose. e cells were centrifuged and
washed with PBS (×3) before being heated at 98∘C for 10
minutes. Yeast viability was then assessed by culture on
Sabouraud dextrose agar to con�rm total cell death.
2.3. Cell Phagocytosis Assay and FACS Analysis. To examine
DC and monocyte-mediated phagocytosis of HKC, the HKC
were initially stained with propidium iodide (PI red �uores-
cent dye). Brie�y, 10𝜇𝜇L of 1mg/mL PI was added to 200𝜇𝜇L
of 107HKC/mL in PBS and incubated for 30 minutes on ice
before washing with cold PBS (×3).
To analyse phagocytosis of the HKC by human PBMCs
and THP-1 cells, the cells were stimulated overnight with
increasing concentrations of LPS followed by addition of
105HKC which had been stained with PI. is preparation
was then cultured for further 2 hours. e cells were then
washed (×3) with cold PBS before �xation of the cells with
2% paraformaldehyde in PBS. Cells without addition of
Candida served as negative controls. Phagocytosis of PI-
stained HKC was measured using �uorescent microscopy
or FACS analysis. Negative controls were used for setting
FACS gating in order to obtain the percentage of cells
that had phagocytosed PI-labelled HKC. An increased PI
�uorescent signal was evident by a shi towards the right in
FL2 histogram plots, which indicated a higher phagocytotic
ability of the cells. In some experiments, human PBMCs were
stained with �uorescein isothiocyanate (FITC) con�ugated
anti-dectin-1 (Abcam, USA). e association of dectin-1
expression with HKC phagocytosis was then detected by
FACS analysis.
2.4. Detection of Dectin-1+ and CD14+ Expression in Human
PBMCs and THP-1 Cells. To detect dectin-1 expression in
human monocytes, with or without LPS stimulation, human
PBMCs and THP-1 cells were cultured overnight with
increasing concentrations of LPS (0, 10, 100, and 200 ng/mL).
Cells expressing dectin-1 were then detected by staining with
an anti-dectin-1 speci�c antibody (Abcam) in combination
with anti-human CD14 antibody (ImmunoTools, Germany)
and isotype control antibodies. Cells were then washed (×3)
with PBS and subsequently �xed in 300 𝜇𝜇L of FACS buﬀer
containing 2% paraformaldehyde. Samples were analyzed by
collecting 10,000 events using a FACSCalibur �ow cytometer
(BD Biosciences, UK). CD14+ cells in PBMC were gated and
increased percentages of dectin-1 positive cells calculated and
compared to cells without LPS stimulation.
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2.5. Real-Time RT-PCR. Total RNA was prepared using
the RNeasy Mini Kit with the QIAshredder spin columns
(QIAGEN) and “on-column” degradation of genomic DNA
with 340 units/mL of RNase-free DNase I (Invitrogen) for
15min. Total RNA (1 𝜇𝜇g) was reverse transcribed into
cDNA using Superscript II RNase H reverse transcriptase
(200 units, Invitrogen) and 100 ng of random primers in
a total volume of 20 𝜇𝜇L for 50min at 42∘C following the
manufacturer’s instructions. Levels of mRNA of dectin-1,
IL-12p40, and IL-23p19 were quanti�ed on an ABI PRISM
7000 Sequence Detection System (Applied Biosystems). e
following primer pairswere used to determine humandectin-
1, IL-12p40, and IL-23p19 mRNA levels in comparison to
the human “housekeeping” GAPDH gene: human dectin-1
sense 5′-GCT TAA TTG GAA AGA AGA GAA GA, anti-
sense 5′-GAT TAA AGG GAA ACA GGT ATC TT; human
IL-12p40 sense 5′-TGA AGA AAG ATG TTT ATG TCG
TAG AAT, anti-sense 5′-GGT CCA AGG TCC AGG TGA
TA; human IL-23p19 sense 5′-AGC TTC ATG CCT CCC
TACT, anti-sense 5′-AGGCTTGGAATCTGCTGAG, and
human GAPDH sense 5′-TCC CGC TTC GCT CTC TGC
TCC TC, and anti-sense 5′-GAC CAGGCGCCC AAT ACG
ACC AAA T. To quantify mRNA levels in cells, relative gene
expression was determined using a SYBR Green qPCR kit
(Bio-Rad, USA), and all samples were run in triplicate. e
cycle threshold (CT) value of each sample was determined
for calculation of the 2−ΔΔ CT the data were expressed as
expression-fold relative to the control.
2.6. IL-23 ELISA. IL-23 levels in cell culture medium were
determined by sandwich ELISA (eBiosciences Inc.) following
the manufacturer’s recommended protocol. Brie�y, wells of a
high protein binding 96-well microtitre plate (Fisher) were
coated overnight at 4∘C with 50 𝜇𝜇L of monoclonal anti-
human IL-23p19p speci�c antibody in 0.1M NaHC�3, pH
�.5. Aer blocking nonspeci�c binding with 10% FBS in PBS
for 2 h at 37∘C, cleared cell supernatants (50 𝜇𝜇L) and human
IL-23 recombinant protein standards (5 ng/mL in double
dilution) were added to the plate in triplicate. IL-23 protein
was captured overnight at 4∘C. Aer thoroughly washing the
plate with PBS containing 0.05% Tween 20, speci�c bound
IL-23 was detected with a biotin-conjugated anti-human IL-
12p40 antibody (2 h at 37∘C), followed by incubation with
StreptAvidin-HRP for 2 h at 37∘C. Results were visualised
by adding 50 𝜇𝜇L of SureBlue TMB peroxidase substrate for
15–30 minutes at room temperature, followed by addition of
50 𝜇𝜇L of the stop solution. e optical density of each well
at 450 nm was determined, and the IL-23 concentration was
calculated based on the IL-23 standards.
2.7. Statistical Analysis. Results were presented as mean ±
standard deviation (SD). All statistical analyses were per-
formed usingMinitab soware. A Student’s 𝑡𝑡-test analysis was
also conducted. A P value of <0.05 was deemed statistically
signi�cant.
3. Results
3.1. Dectin-1 Expression by THP-1 Human Monocytes. To
study the dectin-1 expression by human monocytes, we �rst
examined the dectin-1 expression in THP-1 cells. Without
LPS stimulation, THP-1 cells did not express high levels
of dectin-1 mRNA. LPS stimulation was, however, found
to induce a dose-dependent increase in dectin-1 expression
detected by both RT-qPCR for mRNA and FACS staining for
cell surface protein expression.
GM-CSF and IL-4 are cytokines which normally drive
DC maturation from human PBMC [29]. When THP-1
cells were cultured with 20 ng/mL GM-CSF and 10 ng/mL
IL-4 (concentrations typically used for DC diﬀerentiation),
upregulation of dectin-1was readily detected bymRNA levels
aer 2 h stimulation, and this was further increased aer
24 h (Figure 1(a)). However, the increased levels of dectin-
1 mRNA expression were marginal (ΔΔCT = 0.76 ± 0.20)
and not comparable to those following LPS stimulation in
cultures (ΔΔCT = 10.90 ± 3.61). Indeed, LPS stimulated
signi�cant levels of dectin-1 mRNA at both 2 h and 24 h
poststimulation (Figure 1(a)). FACS analysis showed an LPS
dose-dependent increased dectin-1 expression in THP-1 cells
(Figure 1(b)), and quanti�ed results showed a percentage
increase in dectin-1 positive THP-1 cells with increasing
doses of LPS stimulation (Figure 1(c)).
3.2. Dectin-1 Expression and HKC Phagocytosis in CD14+
Human PBMC aer LPS Stimulation. Populations of newly
isolated human PBMC contain CD14+ monocytes. ese
cells are precursors to macrophages and DCs and are able to
migrate to mucosal tissues where Candida invasion occurs.
To con�rm dectin-1 expression in human PBMCs, PBMC
from healthy human blood donors were stimulated for 0, 2,
and 24 h with 100 ng/mL LPS. Dectin-1 mRNA expression
was examined by RT-qPCR.Without LPS stimulation, freshly
isolated PBMC showed low levels of dectin-1 mRNA expres-
sion. A rapid increase in dectin-1 mRNA level was detected
2 h aer LPS stimulation, and increased dectin-1 expression
was again evident aer 24 h LPS stimulation (Figure 2(a)).
Culture of PBMC in GM-CSF/IL-4 for 7 days resulted in DC
maturation. We also analysed these PBMC-derived DCs for
dectin-1 expression. Higher expression of dectin-1mRNA by
these cells was evident compared with PBMC. In contrast,
challenge with LPS resulted in downregulation of dectin-
1 expression in GM-CSF/IL-4 diﬀerentiated human PBMC
(data not shown), which agrees with previous studies [30, 31].
is indicated that LPS was able to downregulate dectin-1
expression in diﬀerentiated macrophages, but it upregulated
dectin-1 expression in nondiﬀerentiated monocytes.
Aer overnight culture of the isolated human PBMC
in RPMI1640 full medium, approximately 15% of CD14
positive cells became dectin-1 positive monocytes, and these
were readily detected using anti-dectin-1 antibody and FACS
analysis. Further increases in the number of dectin-1 positive
cells were evident with increasing doses of LPS stimulation
(Figure 2(b)).
To investigate the association of monocyte phagocytosis
of C. albicans with dectin-1 expression on monocytes that
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F 1: Dectin-1 expression was induced in a human monocyte (THP-1) cell line by LPS. (a) Dectin-1 RT-qPCR demonstrated increased
expression of mRNA in THP-1 cells at 2 and 24 h aer LPS stimulation. e expression was also increased at the time points with GM-CSF
and IL-4. (b) Cell surface dectin-1 was increased with LPS stimulation in a dose-dependent manner. (c) e percentage of cells with higher
level of dectin-1 expression by FACS analysis. e results were representative of 2 independent experiments.
were freshly isolated from peripheral blood, we stimulated
the cells overnight with increasing concentrations of LPS
(0 to 200 ng/mL) before addition of PI-labelled HKC for
2 h. e cell surface expression of dectin-1 was examined
with an FITC-anti-dectin-1 antibody followed by FACS
analysis. Cells with increased dectin-1 expression were the
cells associated with HKC phagocytosis (Figure 2(c)). is
result demonstrated that LPS was able to upregulate dectin-1
expression in human peripheral bloodmonocytes, and this in
turn enhanced phagocytosis of C. albicans.
3.3. IL-23 Production by Human Monocytes following Chal-
lenge with LPS and then HKC. IL-17 produced by 17 cells
plays an important role in controlling C. albicans infection
[20, 32–35]. IL-23 is a critical cytokine for17 development
and maintenance [32, 36–38]. IL-23 is a heterodimeric
cytokine belonging to the IL-12 family of cytokines and
shares one of its protein subunits (p40) with IL-12, the
other subunit (IL-23p19) is unique to IL-23. Prestimulation
with 10 ng/mL LPS for 2 h followed by challenge with HKC
resulted in both increased IL-12p40 and IL-23p19 mRNA
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F 2: LPS-induced dectin-1 expression in freshly isolated human PBMCs. (a) e relative dectin-1 mRNA expression was detected by
RT-qPCT in hPBMCs at 4 and 24 h aer LPS stimulation. (b)e dectin-1 cell surface expression was shown by FACS staining. (c) Increased
Candida phagocytosis was associated with LPS-induced dectin-1 expression by monocytes. e results were representative of 3 independent
experiments.
expression in THP-1 cells (Figure 3(a)). is con�rmed
that LPS potentially induced human PBMC for Candida
recognition through IL-23 production. THP-1 cells did not
produce detectable levels of IL-23 in cell culture as assessed by
an IL-23 ELISA. However, increased concentrations of IL-23
were produced by THP-1 cells when they were cultured with
increasing concentrations of HKC for 24 h aer 100 ng/mL
LPS Prestimulation for 2 h (Figure 3(b)).is further demon-
strated that LPS together with Candida challenge stimulates
human monocytes for IL-23 production. Most importantly,
IL-17A production was detectable in cultures of human
PBMC aer 3 days with three diﬀerent clinical strains of C.
albicans. is was signi�cantly increased again aer 7 days
with HKC challenge of human PBMCs (Figure 3(c)). IL-
17A detected aer long periods of cell culture may indicate
that dectin-1 and other receptors for Candida recognition
are only elevated aer cell culture since, by FACS analysis,
we could only detect limited levels of dectin-1 expression
in PBMC aer overnight culture without LPS (Figure 2(b)).
Unfortunately, we did not detect IL-23 production in those
cell cultures, which might indicate the consumption of IL-23
by17 cells and other cells with IL-23 receptor expression in
human PBMC cultures, since PBMCs are heterogeneous cell
populations.
4. Discussion
Monocytes in peripheral blood are precursor cells from
bone marrow. Monocytes can further diﬀerentiate into
macrophages and DCs that produce cytokines, particularly
those of the IL-12 family, thus bridging innate and adaptive
immunity. Monocyte and macrophage/DCs are major host
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F 3: Heat-killed Candida-(HKC-) induced IL-23 expression in human monocytes in cell cultures containing LPS. (a) LPS pretreated
human PBMC with HKC challenge and expression of mR�A for IL-12p4� and IL-23p19 subunits of IL-23. A signi�cantly increased IL-23
production in an LPS dose-dependent manner was evident compared to cells without LPS stimulation (∗∗𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃). (b) Human monocytes
cell line (THP-1) produced IL-23 in a dose-dependent manner in the cell cultures together with LPS. (c) Human PBMC produced IL-17A
aer days 1, 3, and 7 cultured with 3 diﬀerent clinical strains of HKC.
innate immune cells that play an important role in controlling
Candida infection. Candida albicans recognition by host
innate immune cells will lead to the production of cytokines,
which stimulate immune cells for pathogen killing. To under-
stand how Candida induces host immune cell recognition
for cytokine production, we isolated clinical strains of C.
albicans and thesewere heat killed before addition to a culture
of human monocytes (THP-1 cell line). Unexpectedly, there
was no detection of members of the IL-12 cytokine family
(IL-12, IL-23, and IL-27) in the cell culture supernatant,
even aer 48 h. In contrast, LPS stimulated high IL-23 and
IL-27 expression and in a dose-dependent manner (data
not shown). ese results indicated that THP-1 cells cannot
recognise heat-killed Candida (HKC) leading to cytokine
production. Dectin-1 is a C-type lectin receptor and key toC.
albicans recognition by binding to the 𝛽𝛽-glucan component
of the yeast cell wall. Recent studies have shown that 𝛽𝛽-
glucan in C. albicans cell wall may actually be masked during
the early stages of infection and then later exposed [39].
As a result, host recognition of Candida via 𝛽𝛽-glucan inter-
action with dectin-1 and subsequent induction of immune
responses and infection control may be less prominent in
early stages of Candida infection compared with later ones.
In our in vitro studies, the extent of potential 𝛽𝛽-glucan
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masking was unknown, and it may have been possible that
heat treatment of the Candida would have increased 𝛽𝛽-
glucan exposure and thus enhanced the observed responses
compared with the in vivo situation. Any enhancement
of 𝛽𝛽-glucan exposure would have been consistent for all
experiments. We maintain that induced dectin-1 expression
by monocytes for recognition of Candida 𝛽𝛽-glucan plays a
key role in controlling both mucosal and systemic Candida
infection in humans, despite potential early masking, and
importantly, dectin-1 gene mutation in patients has been
associated with Candida infection of mucosal skin [16].
In this present study, we found low levels of dectin-1
expression by THP-1 cells cultured in full culture medium.
LPS induced a dose-dependent increase in dectin-1 expres-
sion by these cells, as seen by both mRNA and protein levels.
is was not only evident in THP-1 cells, but also in newly
isolated human PBMC-derived monocytes. THP-1 cells are
precursors of human macrophage/DC cell line which can be
further matured by culture in cell medium containing GM-
CSF. LPS stimulation therefore appears to sensitise human
monocytes for Candida recognition. It has previously been
reported that 𝛽𝛽-glucan together with LPS stimulated a 6-
fold higher IL-10 production by freshly isolated human
monocytes [29]. Stimulation by HKC together with LPS
resulted in THP-1 cells producing an increased quantity of
IL-23, and this was dependent on HKC cell number. is
result suggests that increased dectin-1 expression by LPS
subsequently resulted in higher IL-23 production following
C. albicans challenge. IL-23 is a critical cytokine that drives
andmaintains17 responses.17 cells are a subpopulation
of CD4+ T-cells which are diﬀerentiated from naïve T-cell in
the tissue environment containing TGF𝛽𝛽1, IL-1𝛽𝛽, and IL-23
[40]. C. albicans can drive 17 development with IL-17 and
IFN𝛾𝛾 production, but not with IL-10 [41].
Previously, other groups have shown that mouse and
human matured macrophages and dendritic cells expressed
higher levels of dectin-1, and reduced expression was seen
with LPS stimulation [30, 31, 42, 43]. We have shown
increased dectin-1 expression aer culture of human PBMC
withGM-CSF/IL-4 (to generate typical PBMC-derivedDCs).
Interestingly, LPS was found to downregulate dectin-1
expression in these cells, which agrees with previous reports.
However, monocytes without full maturation expressed
considerably lower levels of dectin-1, and a signi�cantly
increased dectin-1 expression was then observed aer LPS
stimulation. e diﬀerent levels of dectin-1 mRNA expres-
sion for human PBMC and THP-1 cells (as shown by
hDectin-1/hGAPDH ΔΔCT) may be explained by a rela-
tively lower cell number in PBMCs. FACS analysis showed
that about 10% of human PMBCs were CD14+ monocytes.
Amongst these cells, 10% CD14+ monocytes expressed
dectin-1 aer overnight culture with LPS stimulation, whilst
around 55% cells became dectin-1 positive aer 200 ng/mL
LPS stimulation.
In the present study, PBMC cultured with HKC-induced
expression of mRNA for both IL-23 subunits. Although IL-
23p19 mRNA was rapidly and transiently expressed, IL-
12p40 was maintained at a higher level aer 24 h culture. IL-
23 was not detectable by ELISA in human PBMC cell culture
supernatant, and this might indicate its consumption by T-
cells within the culture. IL-17 production was detected in the
cell culture following HKC stimulation, but not in controls
at days 3 and 7. is may indicate that the 17 recalled
response, which requires days to become fully functional. In
this study, three diﬀerent clinical isolates of Candida were
added to the cell cultures, and no signi�cant diﬀerence in
terms of IL-17 production was evident between these strains.
Apart from stimulation of cytokine IL-23 production in
human monocytes by HKC, we also found that increased
expression of dectin-1 in human monocytes was associated
with Candida phagocytosis. It has recently been reported
that 𝛽𝛽-glucan particles bound to dectin-1 in macrophages
form a phagocytic synapse that initiates cell phagocytosis and
cytokine production [14]. �ur results further con�rm that
dectin-1 induced by LPS has a critical role inCandida control.
Within the body, monocytes that migrate from the bone
marrow and circulate in the blood do not require dectin-
1 expression, and this was evident in our study with newly
isolated human PBMC. However, Candida colonisation at
mucosal surfaces will result in the tissue producing GM-
CSF and IL-4 plus various chemokines for recruitment and
maturation ofmonocytes tomacrophages and dendritic cells.
e function of these matured phagocytotic cells will be the
recognition, phagocytosis, and killing of the infecting Can-
dida. Consequently, GM-CSF-induced dectin-1 expression in
macrophages and DCs is essential to prepare these cells for
these purposes. is too was evident in our study, following
incubation of the human PBMC with GM-CSF and IL-4.
It was somewhat surprising that LPS was found to
downregulate dectin-1 expression in matured DCs and
macrophages. Such downregulation is normally associated
with high in�ammatory cytokine production such as TNF𝛼𝛼,
IFN𝛾𝛾, and IL-12p70. At early stages of infection, it could be
that LPS alters human innate immune cells (monocytes) by
stimulating dectin-1 expression leading to C. albicans recog-
nition. However, in later stages and aer these monocytes
have matured into macrophages and DCs with suﬃciently
high dectin-1 cell surface expression, LPS may then trigger
the cell signal to suppress dectin-1 and stimulate proin-
�ammatory cytokine production to enforce in�ammatory
responses.
Understanding the phenotypic changes of macrophages
that occur due to LPS presence is key to elucidating the
mechanisms of wound healing and infection resolution. In
this study, we have shown that LPS is able to induce dectin-
1 expression in human monocytes, and this results in IL-
23 production with enhanced Candida phagocytosis. LPS
may thus alter innate immune cell function for Candida
recognition and aﬀect early stages of Candida infection.
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